4Kawagashira Y, Watanabe H, Morozumi S, et al. Differential response to intravenous immunoglobulin (IVIg) therapy among muhifocal and poly- neuropathy types of painful diabetic neuropathy [ J ]. Journal of clinical ,2010,17(8) :1003 - 1008.
5Han Is, Seo TB, Kim KH, et al. Cde2-mediated Schwarm cell migration during peripheral nerve regeneration[J]. J Cell Sci, 2007, 120(2): 46-255.
6Tan W, Rouen S, Barkus M. et al. Nerve growth factor blocks the glucose-induced down-regulation of caveolin-1 expression in Schwann cells via p75 neurotrophin receptor signaling [J]. J Biol Chem, 2003, 278(25): 23151-23162.
7Shettar A, Muttagi G. Developmental regulation of insulin receptor gene in sciatic nerves and role of insulin on glycoprotein P0 in the Schwann cells[J]. Peptides, 2012, 36(1): 46-53.
8Hidaka H1, Hagiwara M, Chijiwa T. Molecular pharmacology of protein kinases[J]. Neurosci Res, 1989, 15(4): 431-434.
9Nitta A1, Murai R, Suzuki N, et al. Diabetic neuropathies in brain are induced by deficiency ofBDNF[J]. Neurotoxicol Teratol, 2002, 24(5): 695-701.
10Li Z, Zhang J , Liu Z, et al. Downregulation of Bim by brain-derived neurotxophic factor activation of TrKB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death [J]. Cell Death Differ, 2007, 14: 318-326.
